Melendres, Marco B.

HRN: 24-09-39  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/11/2023
CEFTRIAXONE 1G (VIAL)
11/11/2023
11/18/2023
IV
900mg
OD
Periorbital Cellulitis
Waiting Final Action 
11/11/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/11/2023
11/11/2023
IV
120mg
Q8
T/c Periorbital Cellulitis
Waiting Final Action 
11/12/2023
MUPIROCIN 2%, 15G (TUBE)
11/12/2023
11/19/2023
TOPICAL
2%
BID
Furuncle
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: